Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • JER
    Junior Member
    • Sep 2014
    • 4

    Illumina Rapid capture vs. Agilent SureSelect Exon

    I am currently using Illumina's Nextera Rapid capture Enrichment kit for WES Library prep but am about to start a new project and was wondering whether it is worth switching to one of Agilent's SureSelect Exon Kits?

    I've read up on this and it seems a lot of people use Agilent over Illumina, this is probably due to slightly better coverage etc but the Illumina requires less gDNA and is generally cheaper per sample. Does anyone have any recommendations either way?

    Also, are the Agilent kits any good for DNA from FFPE samples?

    Thanks

    (P.S. there is a pdf attached of a paper comparing Agilent SureSelect, Illumina Nextera, Illumina TruSeq and NimbleGen Kits)
    Attached Files
  • idedios
    Member
    • Mar 2014
    • 20

    #2
    I've worked with both Agilent's SureSelect QXT workflow as well as Illumina's Nextera Rapid Capture and I found Agilent's to be quicker and easier to set up. The data was also very clean and it only required one hybridization step as opposed to Illumina's two.
    Another nice thing with Agilent's kit is that you can run small batches of samples without wasting extra reagents whereas Illumina's kit forces you to run in batches of 12 or else you waste oligos and capture reagents.
    The panels I ran were both custom designed (same design for both). Neither company officially support FFPE however it still worked out rather well for me as I ran FFPE exclusively with these kits.
    One odd thing to note is Agilent's kit has a weird problem with the 2nd PCR before sequencing where if you run too many PCR cycles, the sequencing will fail completely (no signal from the cameras). In my case I ran 14 cycles instead of the recommended 12 for my library size since there was confusion about how many cycles to run for a given library size.
    So in conclusion you should use Agilent if you want to work in batches smaller than 12 samples per run.

    Comment

    • Pistachio
      Junior Member
      • Dec 2014
      • 1

      #3
      Thank you very much. You are so helpful.. ~

      Comment

      • ymc
        Senior Member
        • Mar 2010
        • 496

        #4
        Thanks for idedios's input. No wonder SureSelect is dominating this market.

        Do you guys know whether there are official hg38 bed files for SureSelect exome kits? I went to the eArray site but I could find only hg19 bed files. Are hg38 files also there? Anyone knows?

        Comment

        • anujgupta
          Junior Member
          • Nov 2010
          • 7

          #5
          QXT with FFPE

          Originally posted by idedios View Post
          I've worked with both Agilent's SureSelect QXT workflow as well as Illumina's Nextera Rapid Capture and I found Agilent's to be quicker and easier to set up. The data was also very clean and it only required one hybridization step as opposed to Illumina's two.
          Another nice thing with Agilent's kit is that you can run small batches of samples without wasting extra reagents whereas Illumina's kit forces you to run in batches of 12 or else you waste oligos and capture reagents.
          The panels I ran were both custom designed (same design for both). Neither company officially support FFPE however it still worked out rather well for me as I ran FFPE exclusively with these kits.
          One odd thing to note is Agilent's kit has a weird problem with the 2nd PCR before sequencing where if you run too many PCR cycles, the sequencing will fail completely (no signal from the cameras). In my case I ran 14 cycles instead of the recommended 12 for my library size since there was confusion about how many cycles to run for a given library size.
          So in conclusion you should use Agilent if you want to work in batches smaller than 12 samples per run.
          can you share your experimental experiences with QXT for FFPE? Did you modified anything? pls share it to [email protected]

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 12:17 PM
          0 responses
          13 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          37 views
          0 reactions
          Last Post SEQadmin2  
          Working...